Sophie Larrieu

Sophie Larrieu

Auto-generated profile, based on publicly available information

Sophie Larrieu

Department of Mathematical Sciences, University of Stellenbosch, Stellenbosch 7600, South Africa

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MNMouhamad Nasser
Mouhamad Nasser
SLSophie Larrieu
Sophie Larrieu
SSSalim Aymeric Si-Mohamed
Salim Aymeric Si-Mohamed
KAKaïs Ahmad
Kaïs Ahmad
LBLoic Boussel
Loic Boussel
Vincent CottinVincent Cottin
Vincent Cottin
In patients with chronic fibrosing interstitial lung disease (ILD), a progressive fibrosing phenotype (PF-ILD) may develop, but information on the frequency and characteristics of this population outside clinical trials is lacking.We assessed the characteristics and outcomes of patients with PF-ILD other than idiopathic pulmonary fibrosis (IPF) in a real-world, single-centre clinical cohort. The files of all consecutive adult patients with fibrosing ILD (2010–2017) were examined retrospectively for pre-defined criteria of ≥10% fibrosis on high-resolution computed tomography and progressive disease during overlapping windows of 2 years. Baseline was defined as the date disease progression was identified. Patients receiving nintedanib or pirfenidone were censored from survival and progression analyses.In total, 1395 patients were screened; 617 had ILD other than IPF or combined pulmonary fibrosis and emphysema, and 168 had progressive fibrosing phenotypes. In 165 evaluable patients, median age was 61 years; 57% were female. Baseline mean forced vital capacity (FVC) was 74±22% predicted. Median duration of follow-up was 46.2 months. Annualised FVC decline during the first year was estimated at 136±328 mL using a linear mixed model. Overall survival was 83% at 3 years and 72% at 5 years. Using multivariate Cox regression analysis, mortality was significantly associated with relative FVC decline ≥10% in the previous 24 months (p<0.05), age ≥50 years (p<0.01) and diagnosis subgroup (p<0.01).In this cohort of patients with PF-ILD not receiving antifibrotic therapy, the disease followed a course characterised by continued decline in lung function, which predicted mortality.

31 March 2020 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
CCChloé Chamard
Chloé Chamard
SLSophie Larrieu
Sophie Larrieu
CBChristophe Baudouin
Christophe Baudouin
ABAlain Bron
Alain Bron
MVMax Villain
Max Villain
VDVincent Daien
Vincent Daien
Purpose: Preservatives contained in glaucoma eye drops have been shown to have a deleterious impact on the ocular surface. We aimed to assess the association between preservative exposure and the occurrence of further glaucoma surgery among patients with glaucoma or ocular hypertension in France.Methods: The study concerned all patients who first received glaucoma eye drop treatments in a French medical‐administrative database (EGB) between 2008 and 2015. Three groups were created according to the level of preservative exposure during the whole follow‐up: ‘0% preservatives’, ‘mixed’ and ‘100% preservatives’. The occurrence of glaucoma surgery was estimated according to preservative exposure indicators in Cox multivariate models adjusted on age, sex, number of glaucoma eye drops simultaneously used, systemic antihypertensive treatment and duration of treatment.Results: The sample consisted of 12 454 patients. The median (interquartile range) follow‐up was 4.1 (1.7–6.1) years. A total of 231 (1.9%) patients underwent glaucoma surgery during follow‐up. On multivariable analysis, the risk of glaucoma surgery was increased for the ‘mixed’ group (hazard ratio [HR] = 3.94 [95% CI, 1.54–10.05]) and for the ‘100% preservative’ group (HR = 7.97 [95% CI, 3.07–20.67]) when compared with the 0% preservative group.Conclusion: We found an association between exposure to glaucoma eye drop preservatives and the prevalence of further glaucoma surgery. While these data might be used to support the consideration of routine use of preservative‐free drops, in the absence of a randomized clinical trial, they cannot prove a direct cause‐and‐effect relationship between preservative‐free glaucoma eye drops and further glaucoma surgery.

17 December 2020 in Eurosurveillance
Verified
Journal Article
Open access
GSGuillaume Spaccaferri
Guillaume Spaccaferri
SLSophie Larrieu
Sophie Larrieu
JPJérôme Pouey
Jérôme Pouey
CCClémentine Calba
Clémentine Calba
TBThomas Benet
Thomas Benet
PRPatrick Rolland
Patrick Rolland
In France, measures including curfew and lockdown were implemented to control the COVID-19 pandemic second wave in 2020. This study descriptively assesses their possible effects, also relative to their timing. A considerable decrease in incidence of COVID-19 cases and hospital admissions was observed 7 to 10 days after mitigation measures were put in place, occurring earlier in metropolitan areas which had implemented these first. This temporal coincidence suggests the measures’ positive impact, consistent with international experiences.

8 December 2023 in Journal of Algebra and Its Applications
Verified
Journal Article
Closed access
SMSophie Marques
Sophie Marques
DMDaniella Moore
Daniella Moore